All Stories

  1. Quantifying alpha arbutin and niacinamide from nanocosmeceutical formulation matrix: AQbD driven high-performance thin-layer chromatographic method
  2. Compatibility and physicochemical stability of ceftriaxone for injection admixed with pantoprazole sodium and ondansetron hydrochloride in different infusion solutions
  3. MS‐Compatible HPLC Method for Simultaneous Estimation of Ceftriaxone, Pantoprazole, and Ondansetron in Parenteral Formulations and Admixtures
  4. Harnessing Cu- and Fe-based metal-organic frameworks as innovative nanocarriers for enhanced fluconazole delivery in topical management of Candida albicans
  5. Unlocking the potential of novel hybrid lipid polymer nanoparticles in redefining camptothecin delivery: Achieving controlled release, enhanced cytotoxicity, and improved pharmacokinetics for colorectal cancer therapy
  6. AQbD integrated high-performance thin layer chromatographic method for quantitative estimation of Tavaborole in the presence of its degradants and the matrix of nanostructured lipid carriers
  7. Analytical Quality by Design Based HPLC for Quantitative Analysis of Teneligliptin and Rosuvastatin Calcium Tablets in the Presence of Force Degradation Products
  8. Revolutionizing Nitrofurantoin Delivery: Unraveling Challenges and Pioneering Solutions for Enhanced Efficacy in UTI Treatment
  9. Development and Validation of a New Reversed Phase HPLC Method for the Quantitation of Azithromycin and Rifampicin in a Capsule Formulation
  10. A Robust HPLC Approach for Quantitation of Camptothecin in Mesoporous Silica Nanoparticles Matrix and in the Presence of Its Degradation Products
  11. Novel lipid-based nanocarrier of nitrofurantoin for improved oral bioavailability and reduced variability in absorption
  12. Nanoemulsion-Based Strategy for Maximizing Nitrofurantoin Absorption: In-vitro and In-vivo Investigations
  13. DOE supported optimization of biodegradable polymeric nanoparticles based dry powder inhaler for targeted delivery of afatinib in non-small cell lung cancer
  14. Design, characterization, and evaluation of efinaconazole loaded poly(D, L-lactide-co-glycolide) nanocapsules for targeted treatment of onychomycosis
  15. Afatinib liposomal dry powder inhaler: Targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer
  16. Tavaborole microemulsion: New strategy for the targeted treatment of onychomycosis
  17. Analytical Quality by Design-Based Robust RP-HPLC Method for Quantitative Estimation of Pregabalin and Etoricoxib in Fixed-Dose Combination Tablet Formulation
  18. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression
  19. Determination of Asenapine Maleate in Pharmaceutical and Biological Matrices: A Critical Review of Analytical Techniques over the Past Decade
  20. Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies
  21. Design of Experiment Centered Multivariate Optimization Strategy for RP-HPLC Method to Quantitate Retapamulin in Topical Cream and Microemulsion
  22. Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration
  23. Development and validation of HPLC methodology for quantitative estimation of Efinaconazole in topical pharmaceutical formulation prepared in‐house for the treatment of onychomycosis
  24. Brain targeted delivery of lurasidone HCl via nasal administration of mucoadhesive nanoemulsion formulation for the potential management of schizophrenia
  25. RP-HPLC method for quantitative estimation of Efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products
  26. Design, development and optimization of new high performance thin‐layer chromatography method for quantitation of Retapamulin in pharmaceutical formulation: Application of design of experiment
  27. Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches
  28. Efinaconazole: DoE-supported development and validation of a quantitative HPTLC method and its application for the assay of drugs in solution and microemulsion-based formulations
  29. Box-Behnken Experimental Design Aided Optimization of Stability Indicating HPTLC-Based Assay Method: Application in Pharmaceutical Dosage form Containing Model Drugs-Roxithromycin and Ambroxol Hydrochloride
  30. Exploring Potential of Nanocarriers for Therapy of Mycotic Keratitis
  31. Nanoemulsion in drug delivery
  32. Solid phase extraction liquid chromatography mass spectrometry method with electrospray ionization for the determination of Ondansetron in human plasma: Development and validation consideration
  33. Microemulsion for nasal delivery of Asenapine maleate in treatment of schizophrenia: formulation considerations
  34. Validation of stability indicating high performance liquid chromatographic method for estimation of Desloratadine in tablet formulation
  35. Nanoemulsion as a Valuable Nanostructure Platform for Pharmaceutical Drug Delivery
  36. Patents Survey: Treatment of Alzheimer’s Disease Through Nanotechnology-Based Drug Delivery System
  37. Optimization of Robust HPLC Method for Quantitation of Ambroxol Hydrochloride and Roxithromycin Using a DoE Approach
  38. Recent Survey on Patents of Nanoemulsions
  39. Preparation and in vitro/ex vivo evaluation of nanoemulsion for transnasal delivery of paliperidone
  40. Stability-Indicating HPTLC Method for Quantitative Estimation of Asenapine Maleate in Pharmaceutical Formulations, Equilibrium Solubility, andex vivoDiffusion Studies
  41. Formulation consideration and skin retention study of microemulsion containing tazarotene for targeted therapy of acne
  42. Novel microemulsion-based gel formulation of tazarotene for therapy of acne
  43. Novel isotretinoin microemulsion-based gel for targeted topical therapy of acne: formulation consideration, skin retention and skin irritation studies
  44. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation
  45. DEVELOPMENT OF A NEW HIGH-PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD FOR QUANTITATIVE ESTIMATION OF LAMIVUDINE AND ZIDOVUDINE IN COMBINED TABLET DOSAGE FORM USING QUALITY BY DESIGN APPROACH
  46. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration
  47. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study
  48. Stability Indicating Liquid Chromatographic Method for Estimation of Trihexyphenidyl Hydrochloride and Risperidone in Tablet Formulation: Development and Validation Consideration
  49. Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine
  50. STABILITY INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF ADAPALENE IN TABLET FORMULATION
  51. Paliperidone-Loaded Mucoadhesive Microemulsion in Treatment of Schizophrenia: Formulation Consideration
  52. UTLC: An Advanced Technique in Planar Chromatography
  53. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study
  54. Development and Validation of HPTLC Method for Estimation of Carbamazepine in Formulations and Its In Vitro Release Study
  55. HPTLC METHOD FOR ESTIMATION OF ISOTRETINOIN IN TOPICAL FORMULATIONS, EQUILIBRIUM SOLUBILITY SCREENING, AND IN VITRO PERMEATION STUDY
  56. Improving the Isotretinoin Photostability by Incorporating in Microemulsion Matrix
  57. High-Performance Thin-Layer Chromatography (HPTLC)
  58. HPTLc method development and validation for analysis of risperidone in formulations, and in-vitro release study
  59. Experimental Aspects and Implementation of HPTLC
  60. Investigating effect of microemulsion components: In vitro permeation of ketoconazole
  61. HPTLC method development and validation: Quantification of paliperidone in formulations and in vitro release study
  62. HPTLC method for estimation of tazarotene in topical gel formulations and in vitro study
  63. Effect of Formulation Components on the In Vitro Permeation of Microemulsion Drug Delivery System of Fluconazole
  64. Estimation of Alprazolam and Sertraline in Pure Powder and Tablet Formulations by High-Performance Liquid Chromatography and High-Performance Thin-Layer Chromatography